Wockhardt Gets another FDA Warning Letter over GMP Deficiencies

Drug GMP Report
A A
CP Pharmaceuticals, a subsidiary of drug manufacturer Wockhardt Limited, received a warning letter that inspection of its facility revealed significant GMP violations.

To View This Article:

Login

Subscribe To Drug GMP Report